Active surveillance of hepatitis C infection in the UK and Ireland

Archives of Disease in Childhood

Volumn 82, Issue 4, 2000, Pages 286-291

  Gibb, D M ^a   Neave, P E ^a   Tookey, P A ^a   Ramsay, M ^b   Harris, H ^b   Balogun, K ^b   Goldberg, D ^c   Mieli Vergani, G ^d   Kelly, D ^e  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

^c Scottish Centre for Infection and Environmental Health   (United Kingdom)

^d KING S COLLEGE HOSPITAL   (United Kingdom)

^e BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

Hepatitis C infection; Natural history; Surveillance; UK and Ireland

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; ASPARTATE AMINOTRANSFERASE;

ADOLESCENT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHILD; CHILDHOOD DISEASE; FEMALE; HEPATITIS C; HUMAN; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; ORGAN TRANSPLANTATION; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; UNITED KINGDOM; VERTICAL TRANSMISSION;

CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DEMOGRAPHY; FEMALE; GREAT BRITAIN; HEPATITIS C; HUMANS; IRELAND; MALE; PREVALENCE; QUESTIONNAIRES; RISK FACTORS;

EID: 0034071586     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.82.4.286     Document Type: Article

References (24)

1. 1 Anonymous. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention. MMWR Morb Mortal Wkly Rep 1998;47:1-39.
2. 2 Liang TJ. Combination therapy for hepatitis C infection. N Engl J Med 1998;339:1549-50.
3. 3 Alter MJ. Epidemiology of hepatitis C. Hepatology 1997;26: 62-5S.
4. 4 Van der Poel CL, Cuypers HT, Reesink HW. Hepatitis C virus six years on. Lancet 1994;344:1475-9.
5. 5 Seeff LB, Buskell Bales Z, Wright EC, et al. Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group. N Engl J Med 1992;327:1906-11.
6. 6 Honda M, Kaneko S, Unoura M, Kobayashi K, Murakami S. Risk of hepatitis C virus infections through household contact with chronic carriers: analysis of nucleotide sequences. Hepatology 1993;17:971-6.
7. 7 Thomas SL, Newell ML, Peckham CS, Ades AE, Hall AJ. A review of hepatitis C virus (HCV) vertical transmission: risks of transmission to infants born to mothers with and without HCV viraemia or human immunodeficiency virus infection. Int J Epidemiol 1998;27:108-17.
8. 8 Resti M, Azzari C, Mannelli F, et al. Mother to child transmission of hepatitis C virus: prospective study of risk factors and timing of infection in children born to women seronegative for HIV-1. BMJ 1998;317:437-41.
9. 9 Granovsky MO, Minkoff HL, Tess BH, et al. Hepatitis C virus infection in the mothers and infants cohort study. Pediatrics 1998;102:355-9.
10. 10 Spencer JD, Latt N, Beeby PJ, et al. Transmission of hepatitis C virus to infants of human immunodeficiency virus-negative intravenous drug-using mothers: rate of infection and assessment of risk factors for transmission. J Virol Hepat 1997;4:395-409.
11. 11 Thomas DL, Villano SA, Riester KA, et al. Perinatal transmission of hepatitis C virus from human immunodeficiency virus type 1-infected mothers. Women and Infants Transmission Study. J Infect Dis 1998;177:1480-8.
12. 12 Ramsay ME, Balogun MA, Collins M, Balraj V. Laboratory surveillance of hepatitis C virus infection in England and Wales: 1992 to 1996. Commun Dis Public Health 1998;1:89-94.
13. 13 Anonymous. British Paediatric Surveillance Unit 12th Annual Report, 1997-1998. London: BPSU, 1998.
14. 14 Nicoll A, McGarrigle C, Brady AR, et al. Epidemiology and detection of HIV-1 among pregnant women in the United Kingdom: results from national surveillance 1988-96. BMJ 1998;316:253-8.
15. 15 Harris KA, Gilham C, Mortimer PP, Teo CG. The most prevalent hepatitis C virus genotypes in England and Wales are 3a and 1a. J Med Virol 1999;58:127-31.
16. 16 Thomas SL, Newell ML, Peckham CS, Ades AE, Hall AJ. Use of polymerase chain reaction and antibody tests in the diagnosis of vertically transmitted hepatitis C virus infection. Eur J Clin Microbiol Infect Dis 1997;16:711-19.
17. 17 Matsuoka S, Tatara K, Hayabuchi Y, et al. Serologic, virologic, and histologic characteristics of chronic phase hepatitis C virus disease in children infected by transfusion. Pediatrics 1994;94:919-22.
18. 18 Bortolotti F, Resti M, Giacchino R, et al. Hepatitis C virus infection and related liver disease in children of mothers with antibodies to the virus. J Pediatr 1997;130:990-3.
19. 19 García-Monzón C, Jara P, Fernandez-Bermejo M, et al. Chronic hepatitis C in children: a clinical and immunohistochemical comparative study with adult patients. Hepatology 1998;28:1696-701.
20. 20 Bortolotti F, Giacchino R, Vajro P, et al. Recombinant interferon-alfa therapy in children with chronic hepatitis C. Hepatology 1995;22:1623-7.
21. 21 Iorio R, Pensati P, Porzio S, Fariello I, Guida S, Vegnente A. Lymphoblastoid interferon alfa treatment in chronic hepatitis C. Arch Dis Child 1996;74:152-6.
22. 22 McHutchison JG, Gordon SC, Schiff ER, et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med 1998;339: 1485-92.
23. 23 Davis GL, Esteban-Mur R, Rustgi VK, et al. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. N Engl J Med 1998; 339:1493-9.
24. 24 Ramsey M, Alexander G, Robinson A, et al. A national register of HCV infections with a known date of acquisition. Gut 1998;43:209.